- Correction
- Open access
- Published:
Correction: Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)
Journal of Translational Medicine volume 22, Article number: 400 (2024)
The Original Article was published on 23 June 2023
Correction: Journal of Translational Medicine (2023) 21:410 https://doi.org/10.1186/s12967-023-04183-7
Following publication of the original article [1], we have been notified by the authors that Additional files were not published correctly (Tables S1–S3). Also, declarations were not published correctly.
They are now as follows:
Ethics approval and consent to participate
The Mayo Clinic Institutional Review Board granted a waiver of consent for all the available clinical data of the electronic health records of the patients included in the study. All individuals participating in research activities provided written informed consent to a study approved by the Mayo Clinic Institutional Review Board (IRB#: 19-003389).
Consent for publication
Not applicable.
They should be as follows:
Ethics approval and consent to participate
Ethics approval for this retrospective study was granted by the Mayo Clinic Institutional Review Board (IRB#: 19-003389). The IRB provided review and approval for the use of all the available clinical data of the electronic health records of the patients included in this study. All individuals participating in prior research activities mentioned in this study provided written informed consent to a study approved by the Mayo Clinic Institutional Review Board.
Consent for publication
Consent for publication was obtained from the individuals highlighted in the Case Examples section.
The original article was updated.
Reference
Pinto e Vairo F, Kemppainen JL, Vitek CRR, Whalen DA, Kolbert KJ, Sikkink KJ, Kroc SA, Kruisselbrink T, Shupe GF, Knudson AK, Burke EM, Loftus EC, Bandel LA, Prochnow CA, Mulvihill LA, Thomas B, Gable DM, Graddy CB, Garzon GGM, Ekpoh IU, Porquera EMC, Fervenza FC, Hogan MC, El Ters M, Warrington KJ, Davis JM III, Koster MJ, Orandi AB, Basiaga ML, Vella A, Kumar S, Creo AL, Lteif AN, Pittock ST, Tebben PJ, Abate EG, Joshi AY, Ristagno EH, Patnaik MS, Schimmenti LA, Dhamija R, Sabrowsky SM, Wierenga KJ, Keddis MT, Samadder NJJ, Presutti RJ, Robinson SI, Stephens MC, Roberts LR, Faubion WA Jr, Driscoll SW, Wong-Kisiel LC, Selcen D, Flanagan EP, Ramanan VK, Jackson LM, Mauermann ML, Ortega VE, Anderson SA, Aoudia SL, Klee EW, McAllister TM. Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD). J Transl Med. 2023;21:410. https://doi.org/10.1186/s12967-023-04183-7.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Pinto e Vairo, F., Kemppainen, J.L., Vitek, C.R.R. et al. Correction: Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD). J Transl Med 22, 400 (2024). https://doi.org/10.1186/s12967-024-05185-9
Published:
DOI: https://doi.org/10.1186/s12967-024-05185-9